Alerts will be sent to your verified email
Verify EmailRONI
Roni Households
|
Yash Chemex
|
Novelix Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-2.41 % | 7.71 % | -17.5 % |
5yr average Equity Multiplier
|
2.33 | 2.48 | 1.26 |
5yr Average Asset Turnover Ratio
|
0.56 | 1.26 | 0.84 |
5yr Avg Net Profit Margin
|
-0.74 % | 2.39 % | -14.11 % |
Price to Book
|
3.66 | 1.54 | 8.34 |
P/E
|
93.23 | 45.09 | 105.53 |
5yr Avg Cash Conversion Cycle
|
377.84 Days | 150.3 Days | 29.1 Days |
Inventory Days
|
143.96 Days | 40.13 Days | 34.04 Days |
Days Receivable
|
339.45 Days | 144.23 Days | 55.38 Days |
Days Payable
|
249.67 Days | 93.72 Days | 55.7 Days |
5yr Average Interest Coverage Ratio
|
2.6 | 8.19 | -17.77 |
5yr Avg ROCE
|
1.67 % | 11.71 % | -15.4 % |
5yr Avg Operating Profit Margin
|
5.35 % | 2.5 % | -16.49 % |
5 yr average Debt to Equity
|
0.46 | 0.28 | 0.05 |
5yr CAGR Net Profit
|
n/a | n/a | 35.78 % |
5yr Average Return on Assets
|
0.18 % | 3.01 % | -13.36 % |
Shareholdings
|
|||
Promoter Holding
|
60.11 % | 64.38 % | 52.75 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-5.29 % | 4.48 % | -14.17 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Roni Households
|
Yash Chemex
|
Novelix Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|